Research Directory

Value-based drug pricing coming soon in UK

Read more

MorphoSys and Heptares explore new targets

Read more

New role for venture capital in pivotal trials

Read more

JP Morgan - Biotech parades its approvals

Read more

A short history of health technology assessment

Read more

Approvals of cancer drugs set record in 2012

Read more

Do oncolytic viruses have a future as combination therapies?

Read more

Diabetes reimbursement at risk in Germany

Read more

Unitary patent - for better or for worse?

Read more

2012 was the year of the antibody developer

Read more